Introduction {#sec1-1}
============

Renal transplant recipients are at risk from opportunistic infections and occasionally their oncologic manifestations. We report on a renal allograft recipient developing a high-grade urothelial carcinoma with BK virus (BKV) nephropathy 2 years before the detection of the malignancy. BKV was demonstrated in urine, blood, and tumor tissue, suggesting a strong association and possible oncogenicity.

Case Report {#sec1-2}
===========

A 59-year-old female, with end-stage renal disease from hypertension with no prior history of nonsteroidal anti-inflammatory drug intake, received living-related kidney transplantation from her maternal cousin in May 2012. She received induction therapy with three doses of thymoglobulin at 0.9 mg/kg and tacrolimus, mycophenolate mofetil along with prednisolone. She received cytomegalovirus prophylaxis with valganciclovir for 3 months and trimethoprim-sulfamethoxazole for 1 year. The initial 2 years were uneventful except for an episode of diarrhea in March 2014 when serum creatinine peaked to 2.34 mg/dl. Investigations for diarrhea were inconclusive. She received parenteral fluids and antibiotics and recovered with serum creatinine of 1.42 mg/dl. In August 2014, when creatinine increased to 2.1 mg/dl, urine examination revealed trace proteinuria, 1--5 red cells, and some epithelial cells per high-power field and renal histology showed the presence of ground glass intranuclear inclusions within the lining of tubular epithelial cells along with a moderately dense lymphoplasmacytic infiltrate in the interstitium \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. Immunohistochemistry revealed SV-40 antigen in tubular epithelial cells. BKV DNA was identified in the serum -- 2,784,000 copies/ml (Artus BKV RG PCR Kit: QIAGEN GmbH, Germany). In view of BKV nephropathy, mycophenolate mofetil was changed to azathioprine 50 mg once daily, and dose of tacrolimus was reduced targeting a trough \<4.0 ng/ml. Prednisolone was continued at the dose of 5 mg/day. Her serum creatinine ranged from 1.6 to 1.9 mg/dl on follow-up.

![Kidney biopsy: Hematoxylin and eosin stain - ground-glass intranuclear inclusions in tubular epithelial cells](IJN-29-135-g001){#F1}

![Kidney biopsy: Immunohistochemistry showing SV40 positivity in tubular epithelial cells](IJN-29-135-g002){#F2}

In October 2017, she developed pain and hematuria on micturition with clots. She reported loss of appetite and a 4 kg weight loss over 3 months. Examination of urine under high power revealed numerous red cells; decoy cells were not identified with Papanicolaou stains. Ultrasonography revealed two irregular mass lesions -- in the anterior and lateral walls of bladder, respectively. Cystoscopic bladder biopsy showed a high-grade papillary urothelial carcinoma. Immunohistochemistry confirmed positivity for CK7 and GATA-3 and focal positivity for uroplakin \[Figures [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}\]. Tumor cells stained positive for SV-40 \[[Figure 6](#F6){ref-type="fig"}\]. Interestingly, at this time, serum polymerase chain reaction for BKV DNA revealed just 340 copies/ml. Magnetic resonance imaging (MRI) showed deposits encasing the distal right ureter, abutting the vaginal vault along with evidence of adherence to the small bowel loops. Fluorodeoxyglucose (FDG) positron emission tomography (PET) scan revealed FDG avid uptake lesions seen on MRI with no evidence of metastasis.

![Bladder biopsy: Mucosa with extensive ulceration and necrosis; nests and cords of atypical cells, with moderate nuclear atypia and increased mitosis](IJN-29-135-g003){#F3}

![Bladder biopsy: Immunohistochemistry demonstrating tumor areas stained positive for GATA-3](IJN-29-135-g004){#F4}

![Bladder biopsy: Immunohistochemistry demonstrating tumor cells stained positive for CK-7](IJN-29-135-g005){#F5}

![Bladder biopsy: Immunohistochemistry demonstrating tumor cells positive for SV-40; however, adjacent normal urothelium is negative for SV-40](IJN-29-135-g006){#F6}

In view of patient\'s frailty and locally invasive disease, she was treated with 54 Gy of three-dimensional conformal radiation therapy fractionated to 1.8 Gy per session, 5 days weekly for 6 weeks. Tacrolimus was switched to everolimus, while prednisolone was continued. A second FDG-PET showed modest reduction in uptake compared to previous scans with no evidence of distant metastases. The serum creatinine remains around 2.3 mg/dl at the last follow-up.

Discussion {#sec1-3}
==========

The BKV (BK polyomavirus \[BKV\]) was first isolated in 1971, by Gardner *et al*., after inoculation of Vero cells with urine samples from a 39-year-old Sudanese renal allograft recipient with the initials B. K.\[[@ref1]\] Primary infection by BKV is usually in apparent and occasionally be accompanied by a mild respiratory illness or urinary tract symptoms. During the primary infection, when mild respiratory or urinary symptoms may manifest, viremia occurs when latency in organs is established. Immunological impairment leads to reactivation. Virus isolation and Southern blot hybridization analysis have established that kidney is the main site of BKV latency in healthy individuals.\[[@ref2]\] However, BKV has also been detected in the liver, stomach, lungs, parathyroid glands, tonsils, and lymph nodes. Transmission may occur via oral, respiratory, or transplacental routes.

The BKV genome is a closed, circular 5 KB double-stranded DNA molecule that replicates bidirectionally from a unique origin. The early genes encode the large tumor antigen (TAg), the small tumor antigens (tAg), and the truncated TAg that are expressed by alternatively spliced mRNAs soon after infection of the host cell.\[[@ref1]\] The main property of Tag in relation to transformation and oncogenicity is its ability to bind and block the functions of tumor suppressor proteins p53 and pRB family.\[[@ref2]\]

McCabe demonstrated that in the cells lacking retinoblastoma gene, DNA methyltransferase 1 (DNMT1) is activated, which in turn is associated with tumor suppressor gene hypermethylation culminating in tumorigenesis. The same group demonstrated that DNMT1 is strongly activated by BKV Tag.\[[@ref3]\]

Many cases of high-grade urothelial carcinoma occurring in patients with prior BKV nephropathy have been described demonstrating the occurrence; duration between the events ranging from a few months to as long as 5 years \[[Table 1](#T1){ref-type="table"}\]. In many of these cases, the nature of induction and maintenance immunosuppression is unclear.

###### 

Case reports with BK virus demonstrated in urothelial malignancy

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                                             Number of patients   Type of transplant   Induction                    Maintenance            Detection of BKVN             Maintenance immunosuppression used after DX of BKVN   Interval between BKVN and CA bladder   Comments
  --------------------------------------------------- -------------------- -------------------- ---------------------------- ---------------------- ----------------------------- ----------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------
  Roberts *et al*., 2008\[[@ref4]\]                   10                   Kidney               Not specified                Not specified          Not specified                 Not specified                                         Not specified                          

  Emerson *et al*., 2008\[[@ref5]\]                   1                    Kidney               ATG                          Tac\                   Yes                           Sirolimus only                                                                               Graft nephrectomy done 3 years later in view of persistent BK viremia. Graft pathology revealed intraepithelial neoplasia within tubules
                                                                                                                             MMF\                                                                                                                                              
                                                                                                                             steroids                                                                                                                                          

  Hill *et al*., 2009\[[@ref6]\]                      1                    Kidney               Not specified                Tac\                   Yes                           CysA/AZA/steroids                                     About 2 years                          
                                                                                                                             MMF\                                                                                                                                              
                                                                                                                             steroids                                                                                                                                          

  Fernández Rivera *et al*., 2010\[[@ref7]\]          1                    Kidney-pancreas      ATG (1.25 mg/kg × 5 doses)   SirolimusMMFsteroids   Yes                           Sirolimus/steroids                                    Not specified                          Tac to sirolimus in first-month posttransplant in view of hyperglycemia and unrevealing pancreas biopsy

  Galed-Placed and Valbuena-Ruvira, 2011\[[@ref8]\]   1                    Kidney + pancreas    Not specified                Tac/MMF/steroids       Yes                           Not specified                                         About 2 years                          

  Pino *et al*., 2013\[[@ref9]\]                      1                    Kidney               Not specified                Tac/MMF/steroids       Yes                           Not specified                                         5 years                                

  Alexiev *et al*., 2013\[[@ref10]\]                  1                    Kidney-pancreas      Not specified                Not specified          Transplantectomy              Not specified                                                                                

  Alexiev *et al*., 2013\[[@ref10]\]                  1                    Kidney               Not specified                Not specified          Kidney BX negative for BKVN   Not specified                                                                                

  Yin *et al*., 2015\[[@ref11]\]                      1                    Kidney               Not specified                CysA/MMF/steroids      No                            Not specified                                                                                Same dose of immunosuppression postcystectomy

  Salvatore *et al*., 2016\[[@ref12]\]                1                    Kidney               Not specified                Tac/MMF/steroids       Yes                           Not specified                                         5 years                                

  Yan *et al*., 2016\[[@ref13]\]                      13                   Kidney               Variable                     Variable               Variable                      Variable                                              Variable                               31% of all urothelial CA were positive for Tag, and \>50% of invasive urothelial CA were positive for Tag
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BKVN: BK virus nephropathy, MMF: Mycophenolate mofetil, Tac: Tacrolimus, AZA: Azathioprine, CysA: Cyclosporine A, CA: Carcinoma, ATG: Antithymocyte globulin, Tag: T antigen

In this patient, thymoglobulin was used at a lower dose and duration, and the other immunosuppressants too, dosed at a standard range. BK viremia was far lower at the time the malignancy was detected. A declining viremia which may be seen following reduction of immunosuppression may not be predictive of reduction of risk of malignancy in all cases. A protocolized monitoring for BK viremia while reducing the risk of BK nephropathy may avert downstream oncogenicity as well when early reduction in immunosuppression is attempted to thwart viral replication.
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